Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 68

1.

Elevated depressive affect is associated with adverse cardiovascular outcomes among African Americans with chronic kidney disease.

Fischer MJ, Kimmel PL, Greene T, Gassman JJ, Wang X, Brooks DH, Charleston J, Dowie D, Thornley-Brown D, Cooper LA, Bruce MA, Kusek JW, Norris KC, Lash JP; AASK Study Group.

Kidney Int. 2011 Sep;80(6):670-8. doi: 10.1038/ki.2011.153. Epub 2011 Jun 1.

2.

Quality of life and outcomes in African Americans with CKD.

Porter A, Fischer MJ, Wang X, Brooks D, Bruce M, Charleston J, Cleveland WH, Dowie D, Faulkner M, Gassman J, Hiremath L, Kendrick C, Kusek JW, Norris KC, Thornley-Brown D, Greene T, Lash JP; AASK Study Group.

J Am Soc Nephrol. 2014 Aug;25(8):1849-55. doi: 10.1681/ASN.2013080835. Epub 2014 Apr 3.

3.

Sociodemographic factors contribute to the depressive affect among African Americans with chronic kidney disease.

Fischer MJ, Kimmel PL, Greene T, Gassman JJ, Wang X, Brooks DH, Charleston J, Dowie D, Thornley-Brown D, Cooper LA, Bruce MA, Kusek JW, Norris KC, Lash JP; AASK study group.

Kidney Int. 2010 Jun;77(11):1010-9. doi: 10.1038/ki.2010.38. Epub 2010 Mar 3.

4.

Serum aldosterone and death, end-stage renal disease, and cardiovascular events in blacks and whites: findings from the Chronic Renal Insufficiency Cohort (CRIC) Study.

Deo R, Yang W, Khan AM, Bansal N, Zhang X, Leonard MB, Keane MG, Soliman EZ, Steigerwalt S, Townsend RR, Shlipak MG, Feldman HI; CRIC Study Investigators.

Hypertension. 2014 Jul;64(1):103-10. doi: 10.1161/HYPERTENSIONAHA.114.03311. Epub 2014 Apr 21.

5.

Depression and all-cause and cardiovascular mortality in patients on haemodialysis: a multinational cohort study.

Saglimbene V, Palmer S, Scardapane M, Craig JC, Ruospo M, Natale P, Gargano L, Leal M, Bednarek-Skublewska A, Dulawa J, Ecder T, Stroumza P, Marco Murgo A, Schön S, Wollheim C, Hegbrant J, Strippoli GF.

Nephrol Dial Transplant. 2017 Feb 1;32(2):377-384. doi: 10.1093/ndt/gfw016.

PMID:
28186569
6.

Longitudinal changes in hematocrit in hypertensive chronic kidney disease: results from the African-American Study of Kidney Disease and Hypertension (AASK).

Chen TK, Estrella MM, Astor BC, Greene T, Wang X, Grams ME, Appel LJ.

Nephrol Dial Transplant. 2015 Aug;30(8):1329-35. doi: 10.1093/ndt/gfv037. Epub 2015 Mar 27.

7.

Multiple measurements of depression predict mortality in a longitudinal study of chronic hemodialysis outpatients.

Kimmel PL, Peterson RA, Weihs KL, Simmens SJ, Alleyne S, Cruz I, Veis JH.

Kidney Int. 2000 May;57(5):2093-8.

8.

N-terminal prohormone brain natriuretic peptide as a predictor of cardiovascular disease and mortality in blacks with hypertensive kidney disease: the African American Study of Kidney Disease and Hypertension (AASK).

Astor BC, Yi S, Hiremath L, Corbin T, Pogue V, Wilkening B, Peterson G, Lewis J, Lash JP, Van Lente F, Gassman J, Wang X, Bakris G, Appel LJ, Contreras G.

Circulation. 2008 Apr 1;117(13):1685-92. doi: 10.1161/CIRCULATIONAHA.107.724187. Epub 2008 Mar 24.

9.

Quality of life and psychosocial factors in African Americans with hypertensive chronic kidney disease.

Porter A, Fischer MJ, Brooks D, Bruce M, Charleston J, Cleveland WH, Dowie D, Faulkner M, Gassman J, Greene T, Hiremath L, Kendrick C, Kusek JW, Thornley-Brown D, Wang X, Norris K, Unruh M, Lash J.

Transl Res. 2012 Jan;159(1):4-11. doi: 10.1016/j.trsl.2011.09.004. Epub 2011 Oct 12.

10.

Factors associated with depressive symptoms and use of antidepressant medications among participants in the Chronic Renal Insufficiency Cohort (CRIC) and Hispanic-CRIC Studies.

Fischer MJ, Xie D, Jordan N, Kop WJ, Krousel-Wood M, Kurella Tamura M, Kusek JW, Ford V, Rosen LK, Strauss L, Teal VL, Yaffe K, Powe NR, Lash JP; CRIC Study Group Investigators.

Am J Kidney Dis. 2012 Jul;60(1):27-38. doi: 10.1053/j.ajkd.2011.12.033. Epub 2012 Apr 11.

11.

Association of symptoms of depression with progression of CKD.

Tsai YC, Chiu YW, Hung CC, Hwang SJ, Tsai JC, Wang SL, Lin MY, Chen HC.

Am J Kidney Dis. 2012 Jul;60(1):54-61. doi: 10.1053/j.ajkd.2012.02.325. Epub 2012 Apr 10.

PMID:
22495469
12.

Effect of the dynamics of depression symptoms on outcomes after coronary artery bypass grafting.

Foss-Nieradko B, Stepnowska M, Piotrowicz R.

Kardiol Pol. 2012;70(6):591-7. English, Polish.

13.

Survival Disparity of African American Versus Non-African American Patients With ESRD Due to SLE.

Nee R, Martinez-Osorio J, Yuan CM, Little DJ, Watson MA, Agodoa L, Abbott KC.

Am J Kidney Dis. 2015 Oct;66(4):630-7. doi: 10.1053/j.ajkd.2015.04.011. Epub 2015 May 19.

PMID:
26002293
14.

Worsening depressive symptoms are associated with adverse clinical outcomes in patients with heart failure.

Sherwood A, Blumenthal JA, Hinderliter AL, Koch GG, Adams KF Jr, Dupree CS, Bensimhon DR, Johnson KS, Trivedi R, Bowers M, Christenson RH, O'Connor CM.

J Am Coll Cardiol. 2011 Jan 25;57(4):418-23. doi: 10.1016/j.jacc.2010.09.031.

15.

Baseline characteristics of participants in the African American Study of Kidney Disease and Hypertension (AASK) Clinical Trial and Cohort Study.

Sika M, Lewis J, Douglas J, Erlinger T, Dowie D, Lipkowitz M, Lash J, Cornish-Zirker D, Peterson G, Toto R, Kusek J, Appel L, Kendrick C, Gassman J; AASK group.

Am J Kidney Dis. 2007 Jul;50(1):78-89, 89.e1.

PMID:
17591527
16.

Rate of ESRD exceeds mortality among African Americans with hypertensive nephrosclerosis.

Alves TP, Wang X, Wright JT Jr, Appel LJ, Greene T, Norris K, Lewis J; AASK Collaborative Research Group.

J Am Soc Nephrol. 2010 Aug;21(8):1361-9. doi: 10.1681/ASN.2009060654. Epub 2010 Jul 22.

17.

The rationale and design of the AASK cohort study.

Appel LJ, Middleton J, Miller ER 3rd, Lipkowitz M, Norris K, Agodoa LY, Bakris G, Douglas JG, Charleston J, Gassman J, Greene T, Jamerson K, Kusek JW, Lewis JA, Phillips RA, Rostand SG, Wright JT.

J Am Soc Nephrol. 2003 Jul;14(7 Suppl 2):S166-72.

18.

APOL1 risk variants, race, and progression of chronic kidney disease.

Parsa A, Kao WH, Xie D, Astor BC, Li M, Hsu CY, Feldman HI, Parekh RS, Kusek JW, Greene TH, Fink JC, Anderson AH, Choi MJ, Wright JT Jr, Lash JP, Freedman BI, Ojo A, Winkler CA, Raj DS, Kopp JB, He J, Jensvold NG, Tao K, Lipkowitz MS, Appel LJ; AASK Study Investigators; CRIC Study Investigators.

N Engl J Med. 2013 Dec 5;369(23):2183-96. doi: 10.1056/NEJMoa1310345. Epub 2013 Nov 9.

19.

Association of race and body mass index with ESRD and mortality in CKD stages 3-4: results from the Kidney Early Evaluation Program (KEEP).

Babayev R, Whaley-Connell A, Kshirsagar A, Klemmer P, Navaneethan S, Chen SC, Li S, McCullough PA, Bakris G, Bomback A; KEEP Investigators.

Am J Kidney Dis. 2013 Mar;61(3):404-12. doi: 10.1053/j.ajkd.2012.11.038. Epub 2012 Dec 20.

PMID:
23260275
20.

Medication adherence and visit-to-visit variability of systolic blood pressure in African Americans with chronic kidney disease in the AASK trial.

Hong K, Muntner P, Kronish I, Shilane D, Chang TI.

J Hum Hypertens. 2016 Jan;30(1):73-8. doi: 10.1038/jhh.2015.26. Epub 2015 Apr 2.

Supplemental Content

Support Center